США - англійська - NLM (National Library of Medicine)

a-s medication solutions - hepatitis b virus subtype adw hbsag surface protein antigen (unii: xl4hlc6jh6) (hepatitis b virus subtype adw hbsag surface protein antigen - unii:xl4hlc6jh6) - recombivax hb® [hepatitis b vaccine, recombinant] is indicated for prevention of infection caused by all known subtypes of hepatitis b virus. recombivax hb is approved for use in individuals of all ages. recombivax hb dialysis formulation is approved for use in adult predialysis and dialysis patients 18 years of age and older. do not administer recombivax hb to individuals with a history of severe allergic or hypersensitivity reactions (e.g. , anaphylaxis) after a previous dose of any hepatitis b-containing vaccine or to any component of recombivax hb, including yeast [see description (11)] . risk summary all pregnancies have a risk of birth defect, loss, or other adverse outcomes. in the us general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4%, and 15% to 20%, respectively. there are no adequate and well-controlled studies designed to evaluate recombivax hb in pregnant women. available post-approval data do not suggest an in

Австралія - англійська - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - hepatitis a virus antigen; salmonella typhi vi polysaccharide -

Австралія - англійська - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme australia pty ltd - varicella vaccine - live; water for injections -

Малайзія - англійська - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

dr. reddy`s laboratories malaysia sdn. bhd. - rivaroxaban -

Малайзія - англійська - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

dr. reddy`s laboratories malaysia sdn. bhd. - rivaroxaban -

Малайзія - англійська - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

dr. reddy`s laboratories malaysia sdn. bhd. - rivaroxaban -

Ірландія - англійська - HPRA (Health Products Regulatory Authority)

sanofi pasteur msd ltd - varicella virus (oka strain) live attenuated - pdr+solv for susp for inj - > 1350 pfu - varicella zoster vaccines

Сінгапур - англійська - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - varicella virus vaccine live (oka/merck) - injection - 2700 pfu/ml - varicella virus vaccine live (oka/merck) 2700 pfu/ml

Мальта - англійська - Medicines Authority

merck sharp & dohme limited - varicella virus oka/merck strain (live, attenuated) - powder and solvent for suspension for injection - varicella virus oka/merck strain (live, attenuated) - vaccines

Ірландія - англійська - HPRA (Health Products Regulatory Authority)

merck sharp & dohme ireland (human health) limited - varicella virus (oka strain) live attenuated - powder and solvent for suspension for injection - =1350 plaque forming unit - varicella, live attenuated